In its inaugural collaboration that focuses
on small molecule drug discovery, IACS has signed an exclusive agreement with TESARO, Inc., an oncology - focused biopharmaceutical company.
Not exact matches
SOUTH SAN FRANCISCO, Calif. — February 5, 2018 — FLX Bio, Inc., a biopharmaceutical company focused
on the discovery and development of oral
small molecule drugs to activate the immune system against cancer, today announced the appointment of senior pharmaceutical research and development executive Michael F. Giordano, M.D., to its Board of Directors.
The Company focuses
on discovering and developing
small molecule drugs directed against tumor and immune cell targets that control key metabolic pathways in the tumor microenvironment.
The researchers created a new gel, based
on small molecules which self - assemble into nanofibers which could interact with a variety of anti-inflammatory, painkiller
drugs, including iburofen and naproxen.
In the early 2000s, Danishefsky — who is best known for synthesizing Taxol (paclitaxel), a
small -
molecule cancer
drug derived from the Pacific yew tree — set his sights
on synthesizing EPO that would be identical to that in the body.
Basic research
on cancer mechanisms has led to over 40 targeted cancer therapies currently
on the market, which take the form of monoclonal antibodies,
small molecule drugs, and immunotherapies.
Most
drugs on the market today are
small molecules, active organic compounds with a structure and weight so minute that they can be ingested and pass more easily through cell membranes.
This will give way to the development of a
drug to be used in gene therapy against neurodegenerative diseases based
on small molecules which enhance the expression of the gene and / or the use of fragments of the Klotho protein itself.
Anderson and Valerie Grum - Tokars, a junior structural biologist
on the team, developed a three - dimensional structure of human p38 MAPK, enabling the chemists to design and synthesize novel
drug - like
small molecules that would disable it.
«There has been a lot of work
on Wnt signaling pathways, for example, so there are a lot of
small -
molecule drugs that could be tested to trigger a stem cell to mature into a neuron.»
The process of
drug discovery has been dominated in recent years by the screening of large libraries of structurally diverse
small molecules for effects
on target proteins associated with disease.
It is worth noting that «academic
drugs» need not be blockbusters and that most life sciences rely heavily
on small -
molecule effectors (e.g., A23187, phalloidin, or phorbol ester).
In another experiment, a more direct test of druggability, the researchers used a library of
small molecules — broadly representing potential
drug molecules — to see which could compete with the probe in binding covalently to reactive lysines
on human proteins.
SOUTH PLAINFIELD, NJ — December 6, 2007 — PTC Therapeutics, Inc. (PTC), a biopharmaceutical company focused
on the discovery, development, and commercialization of
small -
molecule drugs targeting post-transcriptional control mechanisms, today announced an expanded research collaboration with the Spinal Muscular Atrophy (SMA) Foundation.
The giant firms are counting
on this class of
drugs to bolster profits that will be hurt by the imminent expiration of patents
on many
small -
molecule blockbusters.
TLC's first project, which is also a pilot project of the TRND program, focuses
on repurposing an existing
small molecule drug, auranofin, initially approved to treat rheumatoid arthritis in the mid-1980s.
UniChem supports the integration of high - throughput screening data
on small molecules with chemical libraries and chemical resources for
drug discovery and optimization.
Using the new method, published
on July 31, 2017 in Nature Chemistry, the TSRI scientists identified more than 100 human proteins that are likely to be targetable with
small molecule, pill - based
drugs.
I wish them well
on developing (1) an antibody to detect and image glucosepane in animals (2) a
small molecule drug or enzyme (catabody) to remove the glucosepane (3) luck in finding a development partner for this hypothetical glucosepane breaker.
He served as Laboratory Director at biotech company, Prosetta Corporation, leading several
small molecule drug discovery programs focused
on viruses of interest to the United States Department of Defense.
PTC is a biopharmaceutical company focused
on the discovery, development and commercialization of orally administered, proprietary,
small -
molecule drugs that target post-transcriptional control processes.
A feature article in the same issue of Science provides a perspective
on this research «The Synthesis Machine: An automatic device that makes
small organic
molecules could revolutionize
drug discovery» (full text courtesy of Burke Lab).)
Because LINGO1 has be shown to have a negative impact
on neuronal development and survival, inibiting it with a
small molecule drug may provide an effective approach for developing a treatment for the severe forms of essential tremor.
These alternate strategies include using
small -
molecule drugs that affect RNA metabolism or protein stability, as well as administering modified viruses for therapeutic gene delivery (see «Getting a fix
on SMA»).
PTC is a biopharmaceutical company focused
on the discovery and development of orally administered, proprietary
small -
molecule drugs that target post-transcriptional control processes.
It also raises the possibility to interfere with these systems by any means (
small molecules, FDA approved marketed
drugs) and evaluate the consequences
on both neurogenesis and neuroplasticity.
About PTC Therapeutics PTC is a biopharmaceutical company focused
on the discovery and development of orally administered, proprietary
small molecule drugs that target post-transcriptional control processes.
As reported online in PLoS One
on October 3, Hopkins colorectal cancer specialists John Abraham, Ph.D., and Stephen Meltzer, M.D. - working with the notion that
small molecules generally make better treatment packages - designed
small bits of protein only 10 amino acids long as the foundation for their
drugs.
ORIC Pharmaceuticals, Inc. is a
small molecule oncology company focused
on combating the growing resistance problem to current molecularly targeted
drugs.
ORIC is a
small molecule oncology company focused
on combating the growing resistance problem to current molecularly targeted
drugs.
Discovering novel
small molecule drug leads depends
on the ability to efficiently search chemical diversity.
Its
small molecule drug conjugates are actively target receptors that are over-expressed
on diseased cells.
It focuses
on the development and commercialization of
small molecule drugs for the treatment of central nervous system disorders.
ACADIA Pharmaceuticals Inc. is focused
on the development and commercialization of
small molecule drugs for the treatment of central nervous system disorders.
PTC Therapeutics Inc., is a biopharmaceutical company focused
on the discovery and development of orally administered, proprietary
small -
molecule drugs that target post-transcriptional control processes.
Accomplishments: * Actively consulting
on, discovery and development of Antibody
Drug Conjugates (ADCs) * Actively consulting
on,
small molecules process optimization, scale - up and regulatory aspects * Sepsis diagnostic kits (mAb based) business to Asia for development, manuf.